Hookipa Pharma Inc [NASDAQ: HOOK] closed the trading session at $0.80.
The stocks have a year to date performance of -1.23 percent and weekly performance of -1.89 percent. The stock has been moved at 60.97 percent over the last six months. The stock has performed -0.76 percent around the most recent 30 days and changed 20.14 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 833.39K shares, HOOK reached to a volume of 2256352 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hookipa Pharma Inc [HOOK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOOK shares is $4.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOOK stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Hookipa Pharma Inc shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on December 02, 2022. The new note on the price target was released on December 02, 2022, representing the official price target for Hookipa Pharma Inc stock. Previously, the target price had yet another raise to $6, while Morgan Stanley analysts kept a Equal-Weight rating on HOOK stock.
The Average True Range (ATR) for Hookipa Pharma Inc is set at 0.09, with the Price to Sales ratio for HOOK stock in the period of the last 12 months amounting to 1.48. The Price to Book ratio for the last quarter was 0.76, with the Price to Cash per share for the same quarter was set at 0.94.
HOOK stock trade performance evaluation
Hookipa Pharma Inc [HOOK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.89. With this latest performance, HOOK shares dropped by -0.76% in over the last four-week period, additionally plugging by 60.97% over the last 6 months – not to mention a drop of -43.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOOK stock in for the last two-week period is set at 46.75, with the RSI for the last a single of trading hit 44.01, and the three-weeks RSI is set at 48.43 for Hookipa Pharma Inc [HOOK]. The present Moving Average for the last 50 days of trading for this stock 0.8031, while it was recorded at 0.9072 for the last single week of trading, and 0.6769 for the last 200 days.
Hookipa Pharma Inc [HOOK]: An insightful look at the core fundamentals
Hookipa Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.50 and a Current Ratio set at 4.50.
Earnings per share (EPS) analysis for Hookipa Pharma Inc [HOOK] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOOK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hookipa Pharma Inc go to 14.50%.
Hookipa Pharma Inc [HOOK]: Institutional Ownership
The top three institutional holders of HOOK stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in HOOK stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in HOOK stock with ownership which is approximately 5.8386%.
